Viking Therapeutics, Inc.
NASDAQ:VKTX
30.89 (USD) • At close March 14, 2025
Overview | Financials
Numbers are in millions (except for per share data and ratios) USD.
| 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Assets: | |||||||||||||
| Current Assets: | |||||||||||||
| Cash & Cash Equivalents
| 26.676 | 55.516 | 36.632 | 26.371 | 29.117 | 8.377 | 24.779 | 8.988 | 3.076 | 0.769 | 0.756 | 0.18 | 0 |
| Short Term Investments
| 875.936 | 306.563 | 118.853 | 175.732 | 219.269 | 267.261 | 276.741 | 11.587 | 10.075 | 13.335 | 0 | 0 | 0 |
| Cash and Short Term Investments
| 902.612 | 362.079 | 155.485 | 202.103 | 248.386 | 275.638 | 301.52 | 20.576 | 13.151 | 14.104 | 0.756 | 0.18 | 0 |
| Net Receivables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Inventory
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Current Assets
| 4.604 | 5.146 | 11.555 | 8.425 | 7.718 | 0.405 | 0.278 | 1.276 | 1.649 | 2.195 | 0.018 | 0 | 0 |
| Total Current Assets
| 907.216 | 367.225 | 167.04 | 210.528 | 256.104 | 283.501 | 302.133 | 21.852 | 13.975 | 15.202 | 0.774 | 0.18 | 0 |
| Non-Current Assets: | |||||||||||||
| Property, Plant & Equipment, Net
| 1.003 | 1.126 | 1.418 | 0.025 | 0.321 | 0.598 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Goodwill and Intangible Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Long Term Investments
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Tax Assets
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Assets
| 0.102 | 0.139 | 0.071 | 0.109 | 0.077 | 0.157 | 0.179 | 0.27 | 0.561 | 0.237 | 2.269 | 0.001 | 0 |
| Total Non-Current Assets
| 1.105 | 1.265 | 1.489 | 0.134 | 0.398 | 0.755 | 0.179 | 0.27 | 0.561 | 0.237 | 2.269 | 0.001 | 0 |
| Total Assets
| 908.321 | 368.49 | 168.529 | 210.662 | 256.502 | 284.256 | 302.312 | 22.121 | 14.536 | 15.439 | 3.043 | 0.18 | 0 |
| Liabilities & Equity: | |||||||||||||
| Current Liabilities: | |||||||||||||
| Account Payables
| 9.813 | 7.512 | 8.529 | 1.444 | 3.988 | 2.431 | 0.959 | 1.529 | 1.204 | 0.592 | 1.831 | 0.074 | 0.054 |
| Short Term Debt
| 0.489 | 0.324 | 0.608 | 0.058 | 0.66 | 0.604 | 0 | 3.451 | 3.27 | 0 | 0.304 | 0.047 | 0 |
| Tax Payables
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Revenue
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 2.279 | 1.272 | 0 | 20.323 | 0 | 0 |
| Other Current Liabilities
| 17.111 | 11.299 | 12.81 | 7.276 | 7.481 | 3.742 | 3.591 | 3.677 | 2.003 | 1.384 | 20.382 | 0.007 | 0 |
| Total Current Liabilities
| 27.413 | 19.135 | 21.947 | 8.778 | 12.129 | 6.777 | 4.55 | 8.657 | 6.477 | 1.977 | 22.517 | 0.127 | 0.054 |
| Non-Current Liabilities: | |||||||||||||
| Long Term Debt
| 0.63 | 0.936 | 1.26 | 0 | 0.029 | 0.36 | 0 | 0 | 0 | 2.152 | 1.264 | 0.232 | 0.043 |
| Deferred Revenue Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Deferred Tax Liabilities Non-Current
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Other Non-Current Liabilities
| 0 | 0 | 0 | 0 | 0 | 0 | 0.012 | 0 | 0.016 | 2.586 | 1.39 | 0.072 | 0.008 |
| Total Non-Current Liabilities
| 0.63 | 0.936 | 1.26 | 0 | 0.029 | 0.36 | 0.012 | 4.98 | 0.016 | 4.737 | 2.655 | 0.304 | 0.051 |
| Total Liabilities
| 28.043 | 20.071 | 23.207 | 8.778 | 12.158 | 7.137 | 4.562 | 8.657 | 6.493 | 6.714 | 25.172 | 0.431 | 0.105 |
| Equity: | |||||||||||||
| Preferred Stock
| 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0.004 | 0 |
| Common Stock
| 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0.001 | 0 | 0 | 0 | 0 | 0 | 0 |
| Retained Earnings
| -487.907 | -377.944 | -292.049 | -223.182 | -168.192 | -128.697 | -102.918 | -80.855 | -60.277 | -45.545 | -22.141 | -0.257 | -0.111 |
| Accumulated Other Comprehensive Income/Loss
| -0.788 | -0.389 | -1.102 | -0.549 | -0.054 | 0.012 | -0.423 | -0.02 | -0.007 | -0.007 | 0 | -0.004 | 0 |
| Other Total Stockholders Equity
| 1,368.972 | 726.751 | 438.472 | 425.614 | 412.589 | 405.803 | 401.09 | 94.339 | 68.327 | 54.278 | 0.013 | 0.011 | 0.006 |
| Total Shareholders Equity
| 880.278 | 348.419 | 145.322 | 201.884 | 244.344 | 277.119 | 297.75 | 13.465 | 8.043 | 8.725 | -22.129 | -0.251 | -0.105 |
| Total Equity
| 880.278 | 348.419 | 145.322 | 201.884 | 244.344 | 277.119 | 297.75 | 13.465 | 8.043 | 8.725 | -22.129 | -0.251 | -0.105 |
| Total Liabilities & Shareholders Equity
| 908.321 | 368.49 | 168.529 | 210.662 | 256.502 | 284.256 | 302.312 | 22.121 | 14.536 | 15.439 | 3.043 | 0.18 | 0 |